NephroGenex (NRX) Posts Quarterly Results
NephroGenex (NYSE:NRX) issued its quarterly earnings data on Wednesday. The company reported ($0.37) earnings per share (EPS) for the quarter, AnalystRatingsNetwork.com reports.
Shares of NephroGenex (NYSE:NRX) opened at 5.67 on Wednesday. NephroGenex has a one year low of $5.00 and a one year high of $13.00. The stock has a 50-day moving average of $6.93 and a 200-day moving average of $8.59. The company’s market cap is $50.2 million.
NephroGenex, Inc is a United States-based drug development company focusing on novel therapies for kidney disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.